GAITHERSBURG, Md., Feb. 27, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), today announced that the management team will participate in the following upcoming investor conferences: ...
Transitioned lead commercial responsibility of Nuvaxovid COVID-19 vaccine to Sanofi beginning with the 2025-2026 season Achieved total revenue of $88 million in ...
Researchers at the Wuhan Institute of Virology in China said they discovered a new coronavirus in bats that enters cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback